Ecor1 Capital, Llc's Net Worth
Ecor1 Capital, Llc's net worth is estimated to be at least $165,537,191.69 as of 06/01/2025. CoreStreet's estimation of Ecor1 Capital, Llc's net worth is based on their sale of stock and current holding of stock.
Ecor1 Capital, Llc is Director at Zymeworks Inc. They have executed at least 19 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,919 units of ZYME stock on 05/19/2025. Their biggest sale was on 09/30/2021 when they sold 3,000,000 units of Corvus Pharmaceuticals Inc stock for $15,120,000.00. They typically trade 3 times per year.
Total value of insider buys:
- $145,984,671.69
Total value of insider sells:
- $19,552,520.00
Most recent insider trade:
- May 19, 2025
Ecor1 Capital, Llc's Insider Trading History
| Zymeworks Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 19, 2025 | Director | 5,919 | $11.78 | Buy | $69,725.82 |
May 15, 2025 | Director | 49,502 | $11.43 | Buy | $565,807.86 |
| AnaptysBio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 2, 2025 | Director | 6,646 | $12.95 | Buy | $86,065.70 |
Dec. 30, 2024 | Director | 65,184 | $12.92 | Buy | $842,177.28 |
Aug. 14, 2024 | Major Shareholder | 273,972 | $36.50 | Buy | $9,999,978.00 |
May 5, 2022 | Major Shareholder | 668,237 | $21.63 | Buy | $14,453,966.31 |
April 26, 2021 | Director | 13,900 | $23.80 | Buy | $330,820.00 |
April 23, 2021 | Director | 99,600 | $23.54 | Buy | $2,344,584.00 |
March 8, 2021 | Major Shareholder | 2,777,800 | $18.97 | Buy | $52,694,866.00 |
Feb. 23, 2021 | Major Shareholder | 29,500 | $25.48 | Buy | $751,660.00 |
| Voyager Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 11, 2023 | Major Shareholder | 110,000 | $8.50 | Sell | $935,000.00 |
Jan. 9, 2023 | Major Shareholder | 456,000 | $7.67 | Sell | $3,497,520.00 |
June 23, 2022 | Major Shareholder | 376,000 | $5.66 | Buy | $2,128,160.00 |
June 21, 2022 | Major Shareholder | 101,400 | $5.28 | Buy | $535,392.00 |
| Prothena Corporation plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 5, 2022 | Major Shareholder | 1,062,736 | $29.02 | Buy | $30,840,598.72 |
Jan. 12, 2022 | Major Shareholder | 300,000 | $37.50 | Buy | $11,250,000.00 |
March 24, 2021 | Major Shareholder | 875,000 | $20.75 | Buy | $18,156,250.00 |
Feb. 23, 2021 | Major Shareholder | 44,400 | $21.05 | Buy | $934,620.00 |
| Corvus Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 30, 2021 | Major Shareholder | 3,000,000 | $5.04 | Sell | $15,120,000.00 |